About Prantae
Prantae is a company based in Bhubaneswar (India) founded in 2015 by Sumona Karjee Mishra and Aseem Mishra. It operates as a B2C. Prantae has raised $577.44 thousand across 1 funding round from investors including Indian Angel Network, Samir Kalia and Nitin Zamre. Prantae offers products and services including Proflo-U, Eyera, Embargo, and Covid Testing Kit. Prantae operates in a competitive market with competitors including Quanterix, Biocare Medical, Merck, BioLife Solutions and Telesis Bio, among others.
- Headquarter Bhubaneswar, India
- Founders Sumona Karjee Mishra, Aseem Mishra
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Prantae Solutions Private Limited (Opc)
- Date of Incorporation 01 Jun, 2015
- Jurisdiction Bhubaneswar, Orissa, India
-
Annual Revenue
$25.62 K (USD)-80.39as on Mar 31, 2023
-
Net Profit
-$88.6 K (USD)-9052.88as on Mar 31, 2023
-
EBITDA
-$101.69 K (USD)-52.22as on Mar 31, 2023
-
Total Equity Funding
$577.44 K (USD)
in 1 rounds
-
Latest Funding Round
$577.44 K (USD), Seed
Jan 15, 2025
-
Investors
Indian Angel Network
& 3 more
-
Employee Count
Employee Count
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Prantae
Prantae offers a comprehensive portfolio of products and services, including Proflo-U, Eyera, Embargo, and Covid Testing Kit.
Device for tracking kidney function and self-health monitoring.
Nanosensors for various biosensing applications in health.
Spectroscopes for measuring ultra-sparse biomarkers accurately.
Kit for COVID-19 testing and data export capabilities.
Funding Insights of Prantae
Prantae has successfully raised a total of $577.44K through 1 strategic funding round. The most recent funding activity was a Seed round of $577.44 thousand completed in January 2025. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 1
- Last Round Seed — $577,435
-
First Round
First Round
(15 Jan 2025)
- Investors Count 4
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jan, 2025 | Amount | Seed - Prantae | Valuation | Indian Angel Network |
Investors in Prantae
Prantae has secured backing from 4 investors, including venture fund and angel investors. Prominent investors backing the company include Indian Angel Network, Samir Kalia and Nitin Zamre.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Angel investor network investing in early-stage startups
|
Founded Year | Domain | Location | |
|
SK
Samir Kalia |
-
|
Founded Year | Domain | Location |
|
NZ
Nitin Zamre |
-
|
Founded Year | Domain | Location |
Investments & Acquisitions by Prantae
Financial Statements - Prantae
Prantae Comparisons
Competitors of Prantae
Prantae operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Quanterix, Biocare Medical, Merck, BioLife Solutions and Telesis Bio, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Assay kits for ultra-sensitive biomarker detection are developed.
|
|
| domain | founded_year | HQ Location |
Primary antibodies and instruments for immunohistochemistry are manufactured.
|
|
| domain | founded_year | HQ Location |
Merck is engaged in science and technology solutions globally.
|
|
| domain | founded_year | HQ Location |
Tissue hypothermic storage and cryopreservation freeze media are developed.
|
|
| domain | founded_year | HQ Location |
Online platform offering life sciences reagents and kits
|
|
| domain | founded_year | HQ Location |
Provider of smart solutions for monitoring heart rate, weight, and blood pressure
|
Latest news on Prantae
Frequently Asked Questions about Prantae
Prantae was founded in 2015 and raised its 1st funding round 10 years after it was founded.
Prantae is headquartered in Bhubaneswar, India. It is registered at Bhubaneswar, Odisha, India.
Aseem Mishra is the current CEO of Prantae. They have also founded this company.
Prantae is a funded company, having raised a total of $577.44K across 1 funding round to date. The company's 1st funding round was a Seed of $577.44K, raised on Jan 15, 2025.
Annual revenue of Prantae is $25.62K as on Mar 31, 2023.
Prantae Solutions specializes in creating biomedical devices that enhance diagnosis and support healthcare needs. They employ a structured process involving engineers, designers, and experts to develop safe, effective products focused on science, electronics, and CAD. Offerings include tools for kidney function tracking, biosensing, and COVID testing, aimed at improving user well-being globally through innovative solutions.
Prantae's top competitors include Athelas, Biocare Medical and Merck.
Prantae offers Proflo-U, Eyera, Embargo, and Covid Testing Kit.
Prantae has 4 investors. Key investors include Indian Angel Network, Samir Kalia, Nitin Zamre, and Deepank Kumar.